Paroxetine
Paroxetine is a prescription medication that acts as a serotonin reuptake inhibitor, commonly used to treat depression, anxiety disorders, OCD, and PTSD. This generic version, approved under ANDA212645, is available as extended-release oral tablets in strengths of 12.5 mg, 25 mg, and 37.5 mg, manufactured by Cadila Pharmaceuticals Limited. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Paroxetine is a prescription medication that acts as a serotonin reuptake inhibitor, commonly used to treat depression, anxiety disorders, OCD, and PTSD. This generic version, approved under ANDA212645, is available as extended-release oral tablets in strengths of 12.5 mg, 25 mg, and 37.5 mg, manufactured by Cadila Pharmaceuticals Limited. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Paroxetine",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Paroxetine — ANDA 209293 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209293"
}
]
|
| identifier | ANDA209293 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"fda",
"health-care",
"pharmaceuticals"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Paroxetine |
